We evaluated participants’ body weight, BMI, fasting blood glucose, fasting insulin, and HOMA-IR, as well as HbA1C in six studies that looked at the effects of FMT on weight and glycemic management in obesity and other metabolic disorders. This evidence concerns the gene INS and Other metabolic disease.